As of 2025-09-17, the EV/EBITDA ratio of WAVE Life Sciences Ltd (WVE) is -9.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WVE's latest enterprise value is 1,286.39 mil USD. WVE's TTM EBITDA according to its financial statements is -129.68 mil USD. Dividing these 2 quantities gives us the above WVE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.5x - 19.0x | 8.5x |
| Forward P/E multiples | 4.6x - 16.9x | 7.0x |
| Fair Price | (2.33) - (9.04) | (3.63) |
| Upside | -134.1% - -232.5% | -153.3% |
| Date | EV/EBITDA |
| 2025-09-15 | -10.17 |
| 2025-09-12 | -10.17 |
| 2025-09-11 | -10.49 |
| 2025-09-10 | -10.88 |
| 2025-09-09 | -11.04 |
| 2025-09-08 | -11.20 |
| 2025-09-05 | -12.40 |
| 2025-09-04 | -12.22 |
| 2025-09-03 | -11.91 |
| 2025-09-02 | -14.65 |
| 2025-08-29 | -14.62 |
| 2025-08-28 | -15.18 |
| 2025-08-27 | -15.43 |
| 2025-08-26 | -15.24 |
| 2025-08-25 | -15.19 |
| 2025-08-22 | -15.55 |
| 2025-08-21 | -14.89 |
| 2025-08-20 | -14.37 |
| 2025-08-19 | -14.47 |
| 2025-08-18 | -14.86 |
| 2025-08-15 | -14.89 |
| 2025-08-14 | -13.45 |
| 2025-08-13 | -13.20 |
| 2025-08-12 | -12.68 |
| 2025-08-11 | -12.09 |
| 2025-08-08 | -12.07 |
| 2025-08-07 | -12.13 |
| 2025-08-06 | -12.84 |
| 2025-08-05 | -13.33 |
| 2025-08-04 | -13.18 |
| 2025-08-01 | -12.98 |
| 2025-07-31 | -12.08 |
| 2025-07-30 | -12.19 |
| 2025-07-29 | -12.46 |
| 2025-07-28 | -12.22 |
| 2025-07-25 | -12.59 |
| 2025-07-24 | -12.57 |
| 2025-07-23 | -12.86 |
| 2025-07-22 | -11.80 |
| 2025-07-21 | -11.69 |
| 2025-07-18 | -12.49 |
| 2025-07-17 | -11.93 |
| 2025-07-16 | -11.61 |
| 2025-07-15 | -11.42 |
| 2025-07-14 | -11.64 |
| 2025-07-11 | -11.41 |
| 2025-07-10 | -11.83 |
| 2025-07-09 | -11.41 |
| 2025-07-08 | -10.14 |
| 2025-07-07 | -10.33 |